BTK 蛋白
-
- 抗原 See all BTK 蛋白
- BTK (Bruton Agammaglobulinemia tyrosine Kinase (BTK))
- 蛋白类型
- Recombinant
- 宿主
- 人, 小鼠, 猴, Pig
-
资源
- 大肠杆菌（E. Coli）
- 应用范围
- Western Blotting (WB), Positive Control (PC)
- 原理
- Purified Protein in ready-to-use SDS sample buffer.
- 产品特性
- Phospho specific BTK-selective antibodies were generated against a peptide taken from the human BTK protein spanning AA from 544-561. The BTK-selective antibodies are affinity purified on an immobilized antigen based affinity matrix, the isolated antibodies were then stabilized in antibody stabilization buffer for long-term storage. The anti-BTK-selective antibodies are fully characterized for applications in western blotting and ELISA at the recommended dilutions. The Supplier provides BTK Western blot positive control samples in SDS-PAGE sample buffer.
- 纯化方法
- Purified Protein
- Top Product
- Discover our top product BTK 蛋白
-
Bruton Agammaglobulinemia tyrosine Kinase (BTK) (AA 1-659) protein (GST tag)
BTK 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AA, AP
Bruton Agammaglobulinemia tyrosine Kinase (BTK) (AA 100-189) protein (GST tag)BTK 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AA, AP
Bruton Agammaglobulinemia tyrosine Kinase (BTK) (AA 1-659) protein (DYKDDDDK Tag)BTK 宿主: 人 宿主: HEK-293 Cells Recombinant The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
Bruton Agammaglobulinemia tyrosine Kinase (BTK) (AA 2-659) protein (His tag)BTK 宿主: 人 宿主: 酵母菌 Recombinant > 90 % SDS
Bruton Agammaglobulinemia tyrosine Kinase (BTK) protein (Myc-DYKDDDDK Tag)BTK 宿主: 人 宿主: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
-
- 应用备注
-
Antibodies were tested in ELISA and western blotting applications at 1:500 dilution using ABIN1686581 samples. Antibody dilutions for these antibodies are for reference only, investigators are expected to determine the optimal conditions. Application of this antibody in other protocols has not yet tested.
WB: > 1:500
IMM & IP pull-down assays: n.d.
IHC: n.d.
Investigators using this antibody in protocols other than listed above can request a complimentary sample of this antibody. n.d. not necessarily means the antibody is not suitable for that application, it simply means we have not yet characterized the antibody for that application. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- For 5 applications, volume varies from 100-200 μL in reduced SDS-PAGE sample buffer.
- 储存条件
- -20 °C
- 储存方法
- -20 °C for long term storage
-
- 抗原
- BTK (Bruton Agammaglobulinemia tyrosine Kinase (BTK))
- 别名
- BTK (BTK 产品)
- 别名
- BTK Protein, atk Protein, bpk Protein, xla Protein, imd1 Protein, agmx1 Protein, psctk1 Protein, AGMX1 Protein, AT Protein, ATK Protein, BPK Protein, IMD1 Protein, PSCTK1 Protein, XLA Protein, AI528679 Protein, xid Protein, Bruton tyrosine kinase Protein, Bruton agammaglobulinemia tyrosine kinase Protein, BTK Protein, btk Protein, Btk Protein
- 背景
- Bruton tyrosine kinase (BTK) is a member of the Tec family kinases with a well-characterized role in BCR-signaling and B-cell activation. BTK is activated upstream by Src-family kinases Blk, Lyn, and Fyn, and Btk in turn phosphorylates and activates phospholipase-Cγ (PLCγ), leading to Ca2+ mobilization and activation of NF-κB and MAP kinase pathways. Mutations in BTK gene in humans give rise to X-linked agammaglobulinemia, an inherited disorder that is characterized by severe B cell-specific defects including severely decreased levels of immunoglobulin production and the absence of B cells, suggesting the importance and selectivity of BTK to B cells. Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases. The Bruton tyrosine kinase (Btk) is specifically required for BCR signaling since mutations disrupt Btk function and prevent B-cell maturation at steps that require a functional BCR pathway. Several lines of evidence suggest that the BCR pathway may provide a survival signal in tumor cells in non-Hodgkin lymphoma (NHL). BTK was recently identified as an essential signaling kinase for survival of a subtype of diffuse large B-cell lymphoma. Thus, small molecule BTK inhibitors may provide therapeutic benefit in the treatment of lymphoma and autoimmune diseases.
- 分子量
- 79 kDa
- NCBI登录号
- NP_000052
- UniProt
- Q06187
- 途径
- Fc-epsilon Receptor Signaling Pathway, Hormone Transport, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Toll-Like Receptors Cascades, BCR Signaling
-
